LGF
PFE icon

LGT Group Foundation’s Pfizer PFE Stock Holding History

LGT Group Foundation’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$155K – 291
2022
Q1 		$155K Hold
3,000
– – ﹤0.01% 277
2021
Q4 		$177K Buy
+3,000
New +$149K ﹤0.01% 272

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

LGT Group Foundation's PFE Position: Q1 2026 in Review

LGT Group Foundation increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $5.78M and bringing the position to 2,206,233 shares worth $62M. The position accounts for 0.76% of the portfolio, ranked #30.

LGT Group Foundation first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • LGT Group Foundation held 2,206,233 shares of Pfizer worth $62M as of Q1 2026.
  • LGT Group Foundation bought 216,923 Pfizer shares in Q1 2026, an estimated $5.78M.
  • Pfizer made up 0.76% of LGT Group Foundation's portfolio in Q1 2026, its #30 holding.
  • LGT Group Foundation first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.